Quality

Browse Quality Content

CHPA thanks FDA for providing a process to give feedback from industry leveraging science and risk-based approaches to appropriately identify, assess and control (where needed) NDSRIs and preventing unacceptable levels of nitrosamines in drug products.

Jul 3, 2023

Today, Élan Sudberg, CEO of Alkemist Labs, joins CHPA's Duffy MacKay for an in depth discussion of herbs and botanical testing. Herbs are an important and growing category for dietary supplements, foods, and even cosmetics. When herbs are further processed into botanical dietary supplements, they can be complex products that require extra care in sourcing, manufacturing, and testing.

Jun 5, 2023

Herbs and spices have been part of commerce for thousands and thousands of years, and so have bad actors that substitute less expensive plant material for authentic plants. This practice known as botanical adulteration, has impacted the dietary supplement supply chain. But an industry initiative led by three leading nonprofits has developed a large scale program to reduce ingredient and product adulteration.

May 22, 2023

CHPA’s SVP of Dietary Supplements, Duffy MacKay, responds to reporting on a recent research letter published in JAMA finding that 22 out of 25 melatonin products analyzed were mislabeled, containing variable amounts of the ingredient:

Apr 25, 2023

If you are in the consumer healthcare industry, you probably know about GMPs, or Good Manufacturing Practices. But what do they specifically mean when it comes to dietary supplements, and how do VMS companies prepare for an FDA inspection?

Apr 24, 2023

Join Duffy MacKay, Senior Vice President of Dietary Supplements at CHPA, and George Paraskevakos, Executive Director of the International Probiotics Association to explore the science behind probiotics, why gut health is so important, and what’s next for this growing category.

Jun 13, 2022

CHPA supports efforts to harmonize the current Quality System Regulation with international quality management system requirements. However, CHPA recommends that FDA address several points of concern or clarification when finalizing the Proposed Rule.

May 24, 2022

This week, the Senate Judiciary Committee held a hearing to look into legislative solutions to protect consumers who purchase goods on online platforms, namely the INFORM Consumers Act.

Nov 3, 2021

Filter Results